T Cell News and Research

Latest T Cell News and Research

Experts explain how to decontaminate N95 masks from SARS-CoV-2

Amid the coronavirus global pandemic, the world is facing a shortage of medical supplies, especially those intended to protect health workers. With the high demand for personal protective equipment (PPE), including surgical masks and N95 masks, many people are left with no choice but to try and decontaminate this equipment for extended use. Now, a new study by experts shows how N95 masks can be adequately decontaminated for further use.

16 Apr 2020

Supercomputer helps find 64 compounds as potential inhibitors of the COVID-19 protease

A new study published in Chemrxiv in April 2020 describes the identification of 64 compounds that could potentially be inhibitors of replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is causing the current COVID-19 disease pandemic. The research was carried out using a pharmacophore model of an essential viral enzyme, mining data from the Food and Drug Administration (FDA) database of conformations of approved drugs.

16 Apr 2020

Are overactive immune cells causing COVID-19-related deaths?

While the COVID-19 pandemic is devastating many regions, the world over, a new paper published in the Journal of Experimental Medicine in April 2020 describes the possibility that the critical or very severe cases of COVID-19 are due to the production of neutrophil extracellular traps (NET) due to hyperactivated immune cells.

16 Apr 2020

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

A drug called auranofin, approved for the treatment of rheumatoid arthritis, effectively inhibits severe acute respiratory syndrome coronavirus (SARS-CoV-2) in laboratory conditions, as described in a new study by Georgia State University researchers.

16 Apr 2020

Scripps Research establishes collaborative global effort to rapidly find drugs against COVID-19

With the COVID-19 pandemic continuing to spread across the globe, Scripps Research has quickly established an international network of collaborating scientific laboratories to leverage ReFRAME, the world's leading drug repurposing collection, to find antiviral compounds against the novel coronavirus.

16 Apr 2020

Researchers design peptide inhibitors for potential COVID-19 treatments

Scientists across the globe are rushing to find inhibitors of SARS-CoV-2, the new coronavirus behind the COVID-19 pandemic.

16 Apr 2020

Specialized proteins could soak up excess cytokines in COVID-19 patients

One of the defining features of Covid-19 is the excessive immune response that can occur in severe cases. This burst of immune overreaction, also called a cytokine storm, damages the lungs and can be fatal.

16 Apr 2020

NYU Dentistry receives $2.2 million grant to study role of Schwann cells in oral cancer

The National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, has awarded NYU College of Dentistry's Yi Ye, PhD, a $2.2 million, five-year grant to study the role of Schwann cells, the most prevalent type of cell supporting neurons in the peripheral nervous system, in oral cancer progression and pain.

16 Apr 2020

Review investigates stem cell therapy as potential new treatment for preeclampsia

Preeclampsia is the leading cause of death and disability, for both mothers and babies, killing approximately 76,000 mothers and 500,000 babies globally every year. Despite this, the only cure at present is to deliver the placenta and the baby, with the potential for long term complications.

16 Apr 2020

WHO-recommended hand rub formulations effective against novel coronavirus

When used correctly, both alcohol-based hand disinfectants recommended by the World Health Organization (WHO) are effective against the novel coronavirus Sars-Cov-2, as confirmed by an international research team headed by Professor Stephanie Pfänder from the Department of Molecular and Medical Virology at Ruhr-Universität Bochum.

16 Apr 2020

Drug improves effectiveness of chemotherapy in ovarian cancer patients

An international research team, led by scientists from Mater Research - The University of Queensland, have discovered they can overcome chemotherapy resistance in an ovarian cancer subtype by using low doses of a drug which slows cell growth.

16 Apr 2020

COPD lungs inundated by abnormal stem cells, research finds

Two internationally renowned stem cell experts have found an abundance of abnormal stem cells in the lungs of patients who suffer from Chronic Obstructive Pulmonary Disease, a leading cause of death worldwide.

16 Apr 2020

Entamoeba gingivalis linked to severe and recurrent periodontitis

For the first time, researchers from Charité - Universitätsmedizin Berlin have shown that a unicellular parasite commonly found in the mouth plays a role in both severe tissue inflammation and tissue destruction.

16 Apr 2020

Adult brain cells revert back to embryonic state after injury, study finds

When adult brain cells are injured, they revert to an embryonic state, according to new findings published in the April 15, 2020 issue of Nature by researchers at University of California San Diego School of Medicine, with colleagues elsewhere.

16 Apr 2020

Jails and prisons spring thousands to prevent coronavirus outbreaks

Terry Smith, a 65-year-old Vietnam veteran with PTSD, multiple health issues and a history of homelessness, spent nearly three years in San Francisco County Jail awaiting trial on a burglary charge. The final several weeks were served in the full flush of a burgeoning viral pandemic.

16 Apr 2020

Horizon Discovery offers rapid access to CHOSOURCE platform for development of COVID-19 therapies

Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced special commercial licensing terms to facilitate rapid access to its cGMP-compliant CHOSOURCE platform for the development or production of therapeutic proteins, diagnostic assay components or vaccines relating to COVID-19.

16 Apr 2020

Discovery of specialized gut-brain circuit offers insight into sugar preference

Artificial sweeteners have never fully succeeded in impersonating sugar. Now, a Columbia study in mice has identified a brain mechanism that may explain why.

15 Apr 2020

Screening blood samples for COVID-19 using artificial intelligence

A promising new study published in the preprint online journal medRxiv in April 2020 shows the potential of artificial intelligence (AI) for developing a patient classifier that can separate patients likely to be negative for COVID-19 from among a pool of suspected patients visiting an emergency room (ER).

15 Apr 2020

New therapeutic approach for preserving inflammation-free phases of Crohn's disease

Intestinal stem cell metabolism is facilitated by mitochondria - the in-cell power plants. Chronic inflammation processes inhibit the cells' metabolism and lead to functional loss of these stem cells.

15 Apr 2020

Remdesivir drug stops novel coronavirus from replicating

Scientists from the University of Alberta have published findings that the antiviral drug remdesivir prevents replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by inhibiting RNA replication. The study, published in April 2020 in the Journal of Biological Chemistry, follows on the heels of earlier reports from the same lab in February, showing the drug's effectiveness against the related Middle East Respiratory Syndrome (MERS) virus.

15 Apr 2020

T Cell News and Research

Latest T Cell News and Research

Experts explain how to decontaminate N95 masks from SARS-CoV-2

Supercomputer helps find 64 compounds as potential inhibitors of the COVID-19 protease

Are overactive immune cells causing COVID-19-related deaths?

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

Scripps Research establishes collaborative global effort to rapidly find drugs against COVID-19

Researchers design peptide inhibitors for potential COVID-19 treatments

Specialized proteins could soak up excess cytokines in COVID-19 patients

NYU Dentistry receives $2.2 million grant to study role of Schwann cells in oral cancer

Review investigates stem cell therapy as potential new treatment for preeclampsia

WHO-recommended hand rub formulations effective against novel coronavirus

Drug improves effectiveness of chemotherapy in ovarian cancer patients

COPD lungs inundated by abnormal stem cells, research finds

Entamoeba gingivalis linked to severe and recurrent periodontitis

Adult brain cells revert back to embryonic state after injury, study finds

Jails and prisons spring thousands to prevent coronavirus outbreaks

Horizon Discovery offers rapid access to CHOSOURCE platform for development of COVID-19 therapies

Discovery of specialized gut-brain circuit offers insight into sugar preference

Screening blood samples for COVID-19 using artificial intelligence

New therapeutic approach for preserving inflammation-free phases of Crohn's disease

Remdesivir drug stops novel coronavirus from replicating

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in